Organoid-based modeling of platinum resistance identifies KRT17 as both a response mediator and biomarker for targeted therapy in ovarian cancer
Juliane Reichenbach, Juliana Schmid, Sophia Hierlmayer, Tingyu Zhang, Ilaria Piga, Sophia Geweniger, Jonas Fischer, Aarushi Davesar, Nemanja Vasovic, Anca Chelariu-Raicu, Fabian Bernhard Thaddäus Kraus, Alexander Burges, Bastian Czogalla, Doris Cooper Mayr, Tobias Straub, , Mirjana Kessler
This study identifies KRT17 as a mediator of platinum resistance and a biomarker for targeted therapy in ovarian cancer using organoid models and clinical data.
bioRxiv · Mar 10, 2025 · PreprintCancer Biology